High endogenous avidin binding activity: an inexpensive and readily available marker for the differential diagnosis of kidney neoplasms.
It has been documented that some tissues, such as salivary gland, liver, cardiac and skeletal muscles and kidney, have high level endogenous biotin or endogenous avidin binding activity (EABA). Limited data is available on EABA in renal cell neoplasms. A tissue microarray (TMA) was constructed that included oncocytoma (n=30), chromophobe renal cell carcinoma (RCC) (n=18), clear cell RCC (n=45), clear cell RCC with granular/eosinophilic (G/E) features (n=19), papillary RCC (n=21), papillary RCC with G/E features (n=29) and benign renal tissues (n=31). The TMA slides were stained with or without biotin blocker and analyzed using the automated cellular imaging system (ACIS(R)). Without biotin blocker, a high positive rate of EABA was found in oncocytoma (56/60, 93%) and normal renal tubules (46/60, 77%). A moderate positive rate of EABA was found in clear cell and papillary RCCs with G/E features (13/39, 33% and 19/55, 35%, respectively). Chromophobe RCC and RCC without G/E features had essentially no EABA. With biotin blocker, benign renal tissue and clear cell RCC were negative for EABA; but a significant number of renal oncocytoma (29/60, 48%) and a few papillary RCC with G/E features (5/52, 10%) remained positive for EABA. In conclusion, high EABA may be used to differentiate oncocytoma from chromophobe RCC, and the staining results must be interpreted with caution when avidin-biotin detection system is used in diagnosing renal neoplasms.
Kanehira
Kazunori
K
Department of Pathology, University of Wisconsin Madison, WI, USA.
Hu
Johnny
J
Pier
Thomas
T
Sebree
Linda
L
Huang
Wei
W
Histopathology. 2007 Apr;50(5):642-7
17394501
Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1622-9
12496053
Histopathology. 2004 Nov;45(5):452-9
15500648
Mod Pathol. 2002 Jul;15(7):712-7
12118108
Virchows Arch A Pathol Anat Histopathol. 1983;398(3):291-304
6402840
Virchows Arch. 2005 Dec;447(6):938-46
16133362
J Clin Oncol. 2005 Apr 20;23(12):2763-71
15837991
Chem Biol Interact. 2006 Oct 27;163(1-2):94-112
16765926
J Pathol. 1997 Oct;183(2):131-3
9390023
Am J Clin Pathol. 1999 Jun;111(6):796-803
10361516
J Korean Med Sci. 2007 Apr;22(2):305-10
17449941
Mod Pathol. 2007 Feb;20(2):199-207
17206105
Am J Clin Pathol. 2006 Mar;125(3):392-8
16613342
Mod Pathol. 2005 Apr;18(4):535-40
15502805
J Clin Pathol. 1984 Feb;37(2):223-5
6198343
Arch Pathol Lab Med. 2007 Aug;131(8):1290-7
17683191
Arch Pathol Lab Med. 2007 Oct;131(10):1541-6
17922590
Clin Exp Rheumatol. 1994 Jan-Feb;12(1):45-7
8162641
Histopathology. 2004 Sep;45(3):218-25
15330799
Zhonghua Bing Li Xue Za Zhi. 2002 Dec;31(6):491-6
12622897
Histopathology. 1997 Nov;31(5):400-7
9416479
Nutr Rev. 1975 Apr;33(4):97-102
236527
Mol Cell Probes. 2005 Apr;19(2):87-92
15680209
Hum Pathol. 2005 Mar;36(3):262-8
15791570